PG-011Gel
PG-011-AD-301
Phase 3 small_molecule active
Quick answer
PG-011Gel for Atopic Dermatitis is a Phase 3 program (small_molecule) at Prime Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prime Medicine
- Indication
- Atopic Dermatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active